CF CF Industries Holdings, Inc.
Agricultural Chemicals · NYSE · SEC CIK 1324404 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY17.9%
TTM net income YoY58.2%
TTM EPS YoY71.5%
Revenue 3-yr CAGR1.2%
Net income 3-yr CAGR1.1%
Margins
Gross margin42.5%
Operating margin41.6%
Net margin27.5%
FCF margin26.2%
EBITDA margin53.0%
Returns
ROE41.2%
ROA14.4%
ROIC (approx.)44.2%
Asset turnover0.52x
Leverage & solvency
Liabilities / assets44.7%
Debt / equity0.56x
Current ratio2.98x
Interest coverage11.08x
Cash quality & payout
Operating cash flow / net income1.41x
Accruals ratio-6.0%
Payout ratio14.8%
Capex / revenue12.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $7.08B | $5.94B |
| Cost of revenue | $4.36B | $3.88B |
| Gross profit | $2.72B | $2.06B |
| SG&A expense | $364.00M | $320.00M |
| Operating income | $2.30B | $1.75B |
| Interest expense | $155.00M | $121.00M |
| Pretax income | $2.24B | $1.76B |
| Income tax | $441.00M | $285.00M |
| Net income | $1.46B | $1.22B |
| EBITDA | $3.20B | $2.67B |
| EPS (basic) | 8.98 | 6.75 |
| EPS (diluted) | 8.97 | 6.74 |
| Dividends declared per share | 2.00 | 2.00 |
| Weighted avg. shares (diluted) | 162.20M | 180.70M |
| Balance sheet | ||
| Cash & equivalents | $1.98B | $1.61B |
| Receivables | $488.00M | $404.00M |
| Inventory | $383.00M | $314.00M |
| Current assets | $2.98B | $2.52B |
| PP&E, net | $6.71B | $6.74B |
| Goodwill | $2.49B | $2.49B |
| Intangibles | $473.00M | $507.00M |
| Total assets | $14.09B | $13.47B |
| Current liabilities | $887.00M | $818.00M |
| Long-term debt | $3.21B | $2.97B |
| Total debt | $3.21B | $2.97B |
| Total liabilities | $6.31B | $5.87B |
| Shareholders' equity | $4.84B | $4.99B |
| Net debt | $1.23B | $1.36B |
| Shares outstanding | 153.55M | 169.88M |
| Cash flow statement | ||
| Operating cash flow | $2.75B | $2.27B |
| Capital expenditure | $950.00M | $518.00M |
| Free cash flow | $1.80B | $1.75B |
| Investing cash flow | -$933.00M | -$469.00M |
| Financing cash flow | -$1.48B | -$2.21B |
| Depreciation & amortization | $898.00M | $925.00M |
| Stock-based compensation | $45.00M | $36.00M |
| Dividends paid | $326.00M | $364.00M |
| Share buybacks | $1.36B | $1.51B |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.